Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by joint involvement, extra-articular manifestations, comorbidities, and increased mortality. In the last few decades, the management of RA has been dramatically improved by the introduction of a treat-to-target app...
| 出版年: | Drugs in Context |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BioExcel Publishing Ltd
2019-10-01
|
| 主題: | |
| オンライン･アクセス: | https://www.drugsincontext.com/upadacitinib-and-filgotinib:-the-role-of-jak1-selective-inhibition-in-the-treatment-of-rheumatoid-arthritis/ |